Approval · Notice of Compliance 29002 · 2022
FULVESTRANT INJECTABLE: Notice of Compliance 29002
Issued September 15, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 29002
- Date
- September 15, 2022
- Company
- JAMP Pharma CorporationBoucherville, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Canadian reference product
- FASLODEX
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FULVESTRANT INJECTABLE | 02530635 | Marketed |
Medicinal ingredients
- FULVESTRANT 50 MG per ML